Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-11-12
|
pubmed:abstractText |
Results of a prospective examination (N = 618) of factors associated with smoking relapse are reported. At 1-year follow-up, a modified version of the Fagerstrom Tolerance Questionnaire (Dependence Index; DI) and a measure of craving entered the logistic model (odds ratio of 2.7 [p less than .001]). At Year 2, only the DI entered the model (odds ratio of 2.2 [p less than .001]). The ability of signal detection analysis (SDA) to produce clinically useful decision rules was also examined. At Year 1, SDA produced 1 subgroup with a 25% nonrelapse rate and another with a 9% nonrelapse rate (odds ratio of 3.4 [p less than .001]). At Year 2, SDA produced 1 subgroup with a nonrelapse rate of 19% and another with a nonrelapse rate of 7% (odds ratio of 3.0 [p less than .001]). The use of signal detection methods may help clinicians to identify those at greater or lesser risk of relapse.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-006X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
797-801
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:1401396-Adult,
pubmed-meshheading:1401396-Behavior Therapy,
pubmed-meshheading:1401396-Combined Modality Therapy,
pubmed-meshheading:1401396-Female,
pubmed-meshheading:1401396-Humans,
pubmed-meshheading:1401396-Male,
pubmed-meshheading:1401396-Nicotine,
pubmed-meshheading:1401396-Recurrence,
pubmed-meshheading:1401396-Risk Factors,
pubmed-meshheading:1401396-Smoking,
pubmed-meshheading:1401396-Smoking Cessation,
pubmed-meshheading:1401396-Substance Withdrawal Syndrome
|
pubmed:year |
1992
|
pubmed:articleTitle |
Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation.
|
pubmed:affiliation |
National Institute of Child Health and Human Development, Bethesda, Maryland 20892.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|